Clinical Impact of Post-progression Survival in Patients with Locally Advanced Non-small Cell Lung Cancer After Chemoradiotherapy

BACKGROUND: The efficacy of first-line chemoradiotherapy for overall survival (OS) might be confounded by the subsequent treatments in patients with locally advanced non-small cell lung cancer (NSCLC). In this study, we assessed the associations of progression-free survival (PFS) and post-progressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Hisao, Kobayashi, Daijiro, Kaira, Kyoichi, Kawashima, Sayaka, Masubuchi, Ken, Murata, Masumi, Ebara, Takeshi, Kitamoto, Yoshizumi, Minato, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122299/
https://www.ncbi.nlm.nih.gov/pubmed/35218691
http://dx.doi.org/10.2478/raon-2022-0006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122299/
https://www.ncbi.nlm.nih.gov/pubmed/35218691
http://dx.doi.org/10.2478/raon-2022-0006

Ejemplares similares